Aaron Deykin

Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial

Elliot Israel, Vernon M. Chinchilli, Jean G. Ford et al. · The Lancet · 2004 · 601 citations

Pharmacy, Internal Medicine, Pharmacotherapy +9

Smoking Affects Response to Inhaled Corticosteroids or Leukotriene Receptor Antagonists in Asthma

Stephen C. Lazarus, Vernon M. Chinchilli, Nancy J. Rollings et al. · American Journal of Respiratory and Critical Care Medicine · 2007 · 449 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study

Peter A. Calabresi, Bernd C Kieseier, Douglas L. Arnold et al. · The Lancet Neurology · 2014 · 395 citations

Life Sciences, Immunology, Neurology +9

Daily versus As-Needed Corticosteroids for Mild Persistent Asthma

Homer A. Boushey, Christine A. Sorkness, Tonya S. King et al. · New England Journal of Medicine · 2005 · 383 citations · Full text

Pharmacy, Pharmacotherapy, Inflammation +10

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Raju Kapoor, Pei‐Ran Ho, Nolan Campbell et al. · The Lancet Neurology · 2018 · 337 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +14